DarioHealth Corp. (DRIO)
DRIO Stock Price Chart
Explore DarioHealth Corp. interactive price chart. Choose custom timeframes to analyze DRIO price movements and trends.
DRIO Company Profile
Discover essential business fundamentals and corporate details for DarioHealth Corp. (DRIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
14 Mar 2016
Employees
196.00
Website
https://www.mydario.comCEO
Erez Raphael
Description
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
DRIO Financial Timeline
Browse a chronological timeline of DarioHealth Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.74, while revenue estimate is $5.92m.
Earnings released on 13 May 2026
EPS came in at -$0.81 surpassing the estimated -$1.09 by +25.69%, while revenue for the quarter reached $5.58m , beating expectations by +2.35%.
Earnings released on 19 Mar 2026
EPS came in at -$0.80 surpassing the estimated -$2.44 by +67.21%, while revenue for the quarter reached $5.20m , beating expectations by +3.01%.
Earnings released on 13 Nov 2025
EPS came in at -$1.85 surpassing the estimated -$2.63 by +29.66%, while revenue for the quarter reached $5.01m , missing expectations by -0.82%.
Stock split effective on 28 Aug 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2025
EPS came in at -$2.40 falling short of the estimated -$2.20 by -9.09%, while revenue for the quarter reached $5.37m , missing expectations by -24.24%.
Earnings released on 14 May 2025
EPS came in at -$1.20 surpassing the estimated -$1.40 by +14.29%, while revenue for the quarter reached $6.75m , missing expectations by -13.01%.
Earnings released on 10 Mar 2025
EPS came in at $0.20 surpassing the estimated -$3.20 by +106.25%, while revenue for the quarter reached $7.60m , beating expectations by +0.41%.
Earnings released on 7 Nov 2024
EPS came in at -$2.60 surpassing the estimated -$3.60 by +27.78%, while revenue for the quarter reached $7.42m , beating expectations by +0.16%.
Earnings released on 8 Aug 2024
EPS came in at $1.20 surpassing the estimated -$5.80 by +120.69%, while revenue for the quarter reached $6.26m , missing expectations by -20.92%.
Earnings released on 15 May 2024
EPS came in at -$4.00 surpassing the estimated -$11.80 by +66.10%, while revenue for the quarter reached $5.76m , missing expectations by -14.82%.
Earnings released on 28 Mar 2024
EPS came in at -$8.20 surpassing the estimated -$10.80 by +24.07%, while revenue for the quarter reached $3.62m , beating expectations by +1.29%.
Earnings released on 2 Nov 2023
EPS came in at -$9.80 surpassing the estimated -$10.00 by +2.00%, while revenue for the quarter reached $3.52m , missing expectations by -13.35%.
Earnings released on 10 Aug 2023
EPS came in at -$11.60 falling short of the estimated -$10.40 by -11.54%, while revenue for the quarter reached $6.15m , missing expectations by -6.79%.
Earnings released on 11 May 2023
EPS came in at $9.00 surpassing the estimated -$9.20 by +197.83%, while revenue for the quarter reached $7.07m , missing expectations by -1.17%.
Earnings released on 9 Mar 2023
EPS came in at -$10.20 surpassing the estimated -$12.00 by +15.00%, while revenue for the quarter reached $6.81m , beating expectations by +8.25%.
Earnings released on 14 Nov 2022
EPS came in at -$12.80 surpassing the estimated -$16.60 by +22.89%, while revenue for the quarter reached $6.61m , beating expectations by +4.95%.
Earnings released on 15 Aug 2022
EPS came in at -$14.80 surpassing the estimated -$15.40 by +3.90%, while revenue for the quarter reached $6.18m , missing expectations by -25.07%.
Earnings released on 12 May 2022
EPS came in at -$14.80 surpassing the estimated -$19.60 by +24.49%, while revenue for the quarter reached $8.06m , beating expectations by +18.15%.
Earnings released on 22 Mar 2022
EPS came in at -$21.80 surpassing the estimated -$22.60 by +3.54%, while revenue for the quarter reached $6.03m , beating expectations by +0.19%.
Earnings released on 15 Nov 2021
EPS came in at -$23.60 falling short of the estimated -$19.00 by -24.21%, while revenue for the quarter reached $5.63m , missing expectations by -14.45%.
Earnings released on 16 Aug 2021
EPS came in at -$19.80 falling short of the estimated -$16.80 by -17.86%, while revenue for the quarter reached $5.26m , missing expectations by -9.29%.
DRIO Stock Performance
Access detailed DRIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
